Clinical trial · Interventional
Compare the Operating Condition of Two Levels of Muscle Relaxation on Facial Nerve MEP Monitoring in CPA Surgery
Intraoperative Monitoring of Facial Nerve in Patients Undergoing Cerbellopontine Angle Tumer Resection Using Partial Versus no Neuromuscular Block
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
compare the operating condition of two different levels of muscle relaxation on facial nerve monitoring using transcranial motor evocked potential in CPA surgery . * To Estimate End to start facial nerve MEP amplitude ratio * To determine the effect of neuromuscular relaxant degrees on recovery and * Assessment of propofol doses needed for enhancement of early recovery and ambulation.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cerebellopontine Angle Tumor | Cerebellopontine Angle Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Rocroniom, Non Depolarizing Muscle Relaxant | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- muscle relaxant
- description
- patient who will receive muscle relaxant, patients will receive rocronium infusion by (5 mcg/kg/min) , maintain partial NMB TOF count 2 and targeting BIS = (40-60)
- interventionNames
- Drug: Rocroniom, Non Depolarizing Muscle Relaxant
- type
- PLACEBO_COMPARATOR
- label
- without muscle relaxant
- description
- patient who will not receive muscle relaxant, will recieve normal saline targeting BIS = 40-60.
- interventionNames
- Drug: Rocroniom, Non Depolarizing Muscle Relaxant
Primary outcomes (1)
- measure
- End to start facial nerve MEP amplitude ratio.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 60 Years
Show eligibility criteria text
Inclusion Criteria: * Patients age between \>18 and\<60. * Patients scheduled for neurosurgical CPA surgeries * Ability to sign the consent * ASA classification I, II Exclusion Criteria: * ASA \> II * Hemodynamically unstable * Disease affecting neuromuscular transmission (myasthenia gravies ...etc.) * GCS \< 15. * Any cardiac patient (ischemic heart disease - cardiomyopathy...etc.)
References
Publications (0)
Data not yet available